A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
about
Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonistsPharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.Nepetalactone: a new opioid analgesic from Nepeta caesarea Boiss.Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivoConversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.Molecular Pharmacology of δ-Opioid Receptors.Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter.Molecular mechanisms of opiate receptor coupling to G proteins and effector systems.Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.Downregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes pancreatic cancer cells to TRAIL-induced apoptosis.Effects of morphine and sufentanil preconditioning against myocardial ischemic-reperfusion injury in rabbits.Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node.Repeated delta1-opioid receptor stimulation reduces delta2-opioid receptor responses in the SA node.The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of delta2-opioid receptor stimulation.Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors.Repeated arterial occlusion, delta-opioid receptor (DOR) plasticity and vagal transmission within the sinoatrial node of the anesthetized dog.Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands.Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands.Design of mu selective opioid dipeptide antagonists.Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation.Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
P2860
Q28343629-77A5893E-C0F3-4A94-90F2-F5E541A2A025Q34363972-FCC94263-2FBB-44D7-B084-77BE035537D9Q34409803-9F2B281B-23A8-4D9D-B538-2C7C74D06F5BQ34663559-D2FA65D5-52BB-45AD-AFED-77DE1BB41F47Q34793128-F674C1DB-DE79-4497-82FE-EFAD3AE23A61Q35327954-1D7F7FE2-0304-4200-9231-A6B6C5CE55DCQ36105355-346755BA-BB4C-4BF5-B476-7875FB070D77Q36739024-5BD5DC35-CF74-41CE-AE2E-82A68F4B5CD4Q37062556-2BC53417-DBBC-4050-B393-E42F674466ECQ37320370-7E6EF9D8-565C-427B-963B-6A53D5E78441Q38109239-C87D59D5-58C1-4260-9815-26DBDF6A720DQ38345403-ED147688-B174-42FA-8C59-30D9F027A7EAQ40970985-781EAEAC-7F18-4848-999A-BC78A42341B4Q41951333-4DCFAB60-8794-4A48-86DC-4B4AE3574F27Q42365258-51E85188-FDB8-4208-888D-4BABF30DE3CAQ43156778-E7C69228-463E-4F8D-B302-028A4450D36AQ44183011-9252A757-E5C9-443D-A7FB-9D332CC764FEQ44274447-3FCCA7CB-6B4B-4C1C-B2D1-AF31FCD3FDCBQ44330986-F86B0972-5FEE-42D2-94D8-6C02FA730AFDQ44331180-FF0C03F2-79DF-426E-8A58-1B59724D1616Q44331563-D03408B8-8C86-48F3-B0BB-159D58023CC5Q44340625-85819CB5-1EB6-4E21-B7FB-03B1DD87A88FQ44342205-7C5851AA-12B3-4EA8-8985-5ED73575D8A8Q44343987-2CB091B1-C1D1-45D3-B77B-DE7E758FCC13Q44347480-EE4730BF-7B71-4B4B-97AD-7CB6036266DEQ44348434-647A5DFC-00BB-459E-A2E3-0787C9CCFEE5Q44352654-F5436D2A-8D7E-432C-9E8E-D081D0FB9461
P2860
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@en
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@nl
type
label
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@en
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@nl
prefLabel
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@en
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@nl
P2093
P1476
A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
@en
P2093
Portoghese PS
Takemori AE
P304
P356
10.1016/0014-2999(92)90167-3
P407
P577
1992-07-01T00:00:00Z